In 2025, Danaher’s diagnostics business achieved revenue of $9.94bn out of its $24.57bn total financial performance. By acquiring Masimo, Danaher broadens its diagnostics portfolio in the telehealth ...

VB Spine is to acquire Augmedics’ xvision Spine System to add augmented reality (AR) navigation to its enhanced visualisation offerings.

LEX Diagnostics has secured the US FDA 510(k) clearance and CLIA waiver for its VELO system, a PCR point-of-care diagnostics platform for respiratory pathogens.

Teleradiology provider Medica Group, has reached an agreement to merge Axon Diagnostics into its operations in a move anticipated to advance its remote diagnostic reporting services across the UK ...

QuidelOrtho has signed a strategic supply agreement with Lifotronic Technology to expand its global immunoassay portfolio.

Medtronic has received the US Food and Drug Administration (FDA) clearance for the Stealth AXiS spine surgery robotics ...

One of the key proposals the MHRA seeks feedback on is the ‘indefinite recognition’ of EU CE-marked medical devices in the UK.

Median Technologies’ eyonis (LCS) software, which recently gained FDA clearance, will be integrated into Tempus AI’s cardiac imaging platform.

OncoRes Medical has completed $19.1m private funding round to support the clinical development and regulatory advancement of its QME imaging system, Elora.

Merck and Calla Lily Clinical Care have announced a strategic partnership to advance Callavid, an intravaginal drug delivery platform.

TransMedics Group has received full and unconditional IDE approval from the US FDA for its next-generation OCS ENHANCE Heart ...

Novocure’s Optune Pax delivers electric tumour treating fields (TTFields), targeting the electrical properties of cancer ...